Gara Jalqabaatti › Dhibee Autoimmune › North Carolina › Durham
Qorannoo klinikaalii Dhibee Autoimmune Durham, NC keessatti
Qorannoo 15 Dhibee Autoimmune f Durham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Environmental Risk Factors for the Anti-synthetase Syndrome
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · Miili 7 fagaatti
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Namoota walitti qabaa jiraSadarkaa 3
- Duke University Hospital, Durham
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Namoota walitti qabaa jiraSadarkaa 2/3
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill · Miili 10 fagaatti
Daratumumab in Primary Antiphospholipid Syndrome
Namoota walitti qabaa jiraSadarkaa 1/2
- Duke University, Durham
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Namoota walitti qabaa jiraSadarkaa 1
- Duke University Medical Center, Durham
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Namoota walitti qabaa jiraSadarkaa 3
- Duke University Hospital, Durham
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Namoota walitti qabaa jiraSadarkaa 3
- GSK Investigational Site, Durham
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Namoota walitti qabaa jiraSadarkaa 1/2
- UNC Chapel Hill, Chapel Hill · Miili 10 fagaatti
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Namoota walitti qabaa jiraSadarkaa 2/3
- Duke University, Durham
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Namoota walitti qabaa jiraSadarkaa 3
- Duke University Medical Center, Durham
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Namoota walitti qabaa jiraSadarkaa 3
- Site Number - 1013, Durham
- Site Number - 1020, Chapel Hill · Miili 10 fagaatti
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Namoota walitti qabaa jiraSadarkaa 1
- Duke University, Durham
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Namoota walitti qabaa jiraSadarkaa 1
- Duke University Health System, Durham
Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Duke University, Durham
Qorannoo Dhibee Autoimmune magaalota biroo keessatti
- Houston, TXQorannoo 21
- Washington, DCQorannoo 19
- New York City, NYQorannoo 19
- Philadelphia, PAQorannoo 16
- Boston, MAQorannoo 13
- Los Angeles, CAQorannoo 12
- Chicago, ILQorannoo 12
- Dallas, TXQorannoo 9
- Cleveland, OHQorannoo 8
- Atlanta, GAQorannoo 8
- Milwaukee, WIQorannoo 8
- Portland, ORQorannoo 8
Qorannoo biroo Durham keessatti
- Saree OljooQorannoo 63
- Saree (Gosoota Hunda)Qorannoo 58
- Kansara Qara'a Non-Small CellQorannoo 39
- Myeloma Baay’eeQorannoo 37
- Kansara MetastatikiiQorannoo 33
- Leukemia Myeloidii HamaaQorannoo 33
- Dhibee QaraQorannoo 32
- Kansarii ProstateQorannoo 32
- Kansarii ColorectalQorannoo 28
- Luukemiya Limfoositiikii KeessummaaQorannoo 27
- Kansarii OvariiQorannoo 27
- Cufama OnneeQorannoo 26
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.